Form 4: Guardant Health Director Converts RSUs to Common Stock

Guardant Health Director Steve Krognes converted 155 Restricted Stock Units into common stock on November 30, 2025, increasing his direct common stock holdings.

Summary

• Steve E. Krognes, a Director at Guardant Health, Inc. (GH), reported a transaction on November 30, 2025.
• The transaction involved the conversion of 155 Restricted Stock Units (RSUs) into 155 shares of Guardant Health Common Stock.
• The conversion price for the RSUs was $0.
• Following this transaction, Krognes directly beneficially owns 18,591 shares of Common Stock.
• He also directly beneficially owns 1,080 Restricted Stock Units.
• The RSUs involved were part of an award granted on August 9, 2022, with 25% vesting on June 30, 2023, and the remaining 75% vesting in substantially equal monthly installments over three years from June 30, 2023.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive. While a routine transaction, the conversion of RSUs into common stock by a director increases their direct equity stake, which can be interpreted as a minor signal of continued confidence in the company's future performance.

Positives

• A Director, Steve E. Krognes, increased his direct beneficial ownership of Guardant Health common stock by 155 shares through the conversion of Restricted Stock Units, which can be viewed as a minor positive signal of insider confidence.

Future Outlook

The filing does not contain forward-looking statements or guidance beyond the vesting schedule of the reported Restricted Stock Units.

Industry Context

This is a routine insider transaction (conversion of equity compensation) and does not provide specific insights into broader industry trends or competitive positioning.

Stakeholder Impact

• Shareholders: The increase in direct common stock ownership by a director may be viewed as a minor positive signal of insider alignment and confidence in the company's prospects.

Next Steps

• The remaining 75% of the Restricted Stock Unit award will continue to vest in substantially equal installments on each monthly anniversary of June 30, 2023, over a three-year period.

Key Dates

Keywords

Guardant Health, GH, Steve Krognes, Insider Transaction, Form 4, Restricted Stock Units, RSU Conversion, Common Stock, Director Holdings